Welcome to our dedicated page for Ducommun Incorporated news (Ticker: $DCO), a resource for investors and traders seeking the latest updates and insights on Ducommun Incorporated stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Ducommun Incorporated's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Ducommun Incorporated's position in the market.
Ducommun Incorporated reported record Q1 revenue of $190.8 million, a 5.3% increase from Q1 2023. The net income was $6.8 million, up 70 bps year-over-year. Gross margin grew to 24.6%, a 430 bps increase, and adjusted EBITDA reached $27.4 million, up 170 bps. The Company highlighted strong performance in Commercial Aerospace and progress in their Vision 2027 Plan. Ducommun remains optimistic about achieving its long-term goals.
